<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01793129</url>
  </required_header>
  <id_info>
    <org_study_id>NICHD-NRN-0051</org_study_id>
    <secondary_id>U10HD021364</secondary_id>
    <secondary_id>U10HD040689</secondary_id>
    <secondary_id>U10HD021385</secondary_id>
    <secondary_id>U10HD027851</secondary_id>
    <secondary_id>U10HD027853</secondary_id>
    <secondary_id>U10HD027856</secondary_id>
    <secondary_id>U10HD027904</secondary_id>
    <secondary_id>U10HD027880</secondary_id>
    <secondary_id>U10HD034216</secondary_id>
    <secondary_id>U10HD021373</secondary_id>
    <secondary_id>U10HD040492</secondary_id>
    <secondary_id>U10HD053109</secondary_id>
    <secondary_id>U10HD040461</secondary_id>
    <secondary_id>U10HD068244</secondary_id>
    <secondary_id>U10HD068263</secondary_id>
    <secondary_id>U10HD068270</secondary_id>
    <secondary_id>U10HD068278</secondary_id>
    <secondary_id>U10HD068284</secondary_id>
    <secondary_id>U10HD036790</secondary_id>
    <secondary_id>UG1HD087226</secondary_id>
    <nct_id>NCT01793129</nct_id>
  </id_info>
  <brief_title>Preemie Hypothermia for Neonatal Encephalopathy</brief_title>
  <official_title>A Randomized Trial of Targeted Temperature Management With Whole Body Hypothermia For Moderate And Severe Hypoxic-Ischemic Encephalopathy In Premature Infants 33-35 Weeks Gestational Age.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NICHD Neonatal Research Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>NICHD Neonatal Research Network</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a randomized, controlled trial to assess safety and effectiveness of whole body
      hypothermia for 72 hours in preterm infants 33-35 weeks gestational age (GA) who present at
      &lt;6 hours postnatal age with moderate to severe neonatal encephalopathy (NE). The study will
      enroll infants with signs of NE at 18 NICHD Neonatal Research Network sites, and randomly
      assign them to either receive hypothermia or participate in a non-cooled control group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Most clinical studies of neonatal encephalopathy (NE) and potential interventions have
      focused on infants ≥36 weeks GA. Although many interventions have been suggested and assessed
      for prevention or palliation of NE, the only one currently supported by rigorous clinical
      evidence to improve outcome in human newborns has been hypothermia implemented at &lt;6 hours of
      postnatal age and maintained for 72 hrs. Data about diagnosis, frequency, severity, and
      outcome of NE in infants 33-35 weeks GA are sparse.

      This trial will assess safety and effectiveness of whole body hypothermia for 72 hours in
      preterm infants 33-35 weeks gestational age (GA) who present at &lt;6 hrs postnatal age with
      moderate to severe neonatal encephalopathy. Infants 33 0/7 to 35 6/7 weeks GA (best
      obstetrical estimate) and greater than or equal to 1500 grams birth weight (selected to
      minimize potential difficulties placing esophageal probe) who meet clinical, biochemical and
      neurologic criteria for moderate to severe NE will be randomized to either whole body
      hypothermia or participate in a non-cooled control group. The primary outcome will be death
      or moderate to severe disability at 18-22 months corrected age. The presence or absence of
      disability will be determined by the standard NRN interdisciplinary follow-up exam.

      Secondary Study includes determining an association between MRI detectable injury and
      neurodevelopment at 18-22 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Death or moderate or severe disability</measure>
    <time_frame>Birth to 18-22 months corrected age</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of deaths in the NICU and following discharge</measure>
    <time_frame>Birth to 18-22 months corrected age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in MRI findings after cessation of cooling/control obtained</measure>
    <time_frame>Birth to 40 weeks corrected age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of infants with moderate and severe disability</measure>
    <time_frame>Birth to 18-22 months corrrected age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Causes of Death</measure>
    <time_frame>Birth to 18-22 months corrrected age</time_frame>
    <description>withdrawal of support and reasons for such will be tracked; attempts will be made to obtain autopsy whenever possible</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological injury by cranial ultrasound within 24 hours of enrollment</measure>
    <time_frame>Birth to 2 days of life</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">168</enrollment>
  <condition>Infant, Newborn</condition>
  <condition>Hypoxia, Brain</condition>
  <condition>Hypoxia-Ischemia, Brain</condition>
  <condition>Encephalopathy, Hypoxic-Ischemic</condition>
  <condition>Hypoxic-Ischemic Encephalopathy</condition>
  <condition>Ischemic-Hypoxic Encephalopathy</condition>
  <arm_group>
    <arm_group_label>Whole-body Hypothermia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Induced Whole-body hypothermia (with a target esophageal temperature of 33.5°C) for 72 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normothermia</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control group (with esophageal temperature at or near 37.0°C) for 72 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hypothermia</intervention_name>
    <description>Induced Whole-body hypothermia (with a target esophageal temperature of 33.5°C) for 72 hours</description>
    <arm_group_label>Whole-body Hypothermia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Normothermic Control</intervention_name>
    <description>Normothermic Control group (with esophageal temperature at or near 37.0°C) for 96 hours</description>
    <arm_group_label>Normothermia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants 33 0/7 to 35 6/7 weeks GA (best obstetrical estimate)

          -  Infants weight greater than or equal to 1500 grams at birth

          -  Postnatal age less than 6 hours

          -  Infants who meet clinical, biochemical and neurologic criteria for moderate to severe
             NE:

        Biochemical: Cord gas or blood gas within first hour of life with pH ≤7.00 or base deficit
        (BD) ≥16 mEq/L OR

        Acute perinatal event (e.g., abruptio placenta, cord prolapse, uterine rupture, severe FHR
        abnormality such as variable or late decelerations) AND Requirement for positive pressure
        ventilation for apnea or poor respiratory effort since birth for at least 10 minutes OR 10
        minute Apgar score ≤5

        AND

        Neurologic:

        Seizures OR modified Sarnat score with abnormalities in at least 3 of the 6 categories; at
        least one must be altered level of consciousness (lethargy or stupor/coma) as determined by
        a certified examiner (All infants who meet criteria for potential inclusion will undergo
        standard neurologic exam as for infants ≥36 wks GA being considered for hypothermia, with
        findings recorded)

        Exclusion Criteria:

          -  Receipt of sedative, analgesic or paralytic agent that may confound the qualifying
             neurologic exam

          -  Etiology of NE not likely to be hypoxic-ischemic in origin

          -  Major congenital anomaly that may confound outcome

          -  Considered to be moribund and will not be receiving full intensive care

          -  Equipment and/or appropriate staff not available

          -  Core temperature &lt; 33.5oC for more than one hour at time of screening

          -  Unable to randomize by 6 hours of age

          -  Infant needs ECMO

          -  All blood gases (cord and postnatal at &lt; 1hr of age) have a pH &gt; 7.15 AND a base
             deficit &lt; 10mEq/L
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>33 Weeks</minimum_age>
    <maximum_age>35 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michele C Walsh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Case Western Reserve University, Rainbow Babies and Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seetha Shankaran, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wayne State University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abbot R Laptook, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brown University, Women &amp; Infants Hospital of Rhode Island</affiliation>
  </overall_official>
  <overall_official>
    <last_name>C. Michael Cotten, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David P Carlton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Greg Sokol, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abhik Das, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>RTI International</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Krisa P Van Meurs, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brenda Poindexter, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wally A Carlo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Edward F Bell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kristi L Watterberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of New Mexico</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Myra Wyckoff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Southwestern Medical Center at Dalla</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jon E Tyson, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eric Eichenwald, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carl T D'Angio, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rochester</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pablo Sanchez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Institute at Nationwide Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bradley Yoder, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roger G Faix, MD</last_name>
    <phone>801-581-7052</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rosemary D Higgins, MD</last_name>
    <phone>301-435-5575</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Waldemar A. Carlo, MD</last_name>
    </contact>
    <investigator>
      <last_name>Waldemar A. Carlo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krisa P. Van Meurs, MD</last_name>
    </contact>
    <investigator>
      <last_name>Krisa P. Van Meurs, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David P Carlton, MD</last_name>
    </contact>
    <investigator>
      <last_name>David P Carlton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edward F. Bell, MD</last_name>
    </contact>
    <investigator>
      <last_name>Edward F. Bell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wayne State University</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of New Mexico</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristi L. Watterberg, MD</last_name>
    </contact>
    <investigator>
      <last_name>Kristi L. Watterberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carl T D'Angio, MD</last_name>
    </contact>
    <investigator>
      <last_name>Carl T D'Angio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>RTI International</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>C. Michael Cotten, MD</last_name>
    </contact>
    <investigator>
      <last_name>C. Michael Cotten, MD MHS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brenda Poindiexter, MD</last_name>
    </contact>
    <investigator>
      <last_name>Brenda Poindexter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Case Western Reserve University, Rainbow Babies and Children's Hospital</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele C. Walsh, MD, MS</last_name>
    </contact>
    <contact_backup>
      <last_name>S.</last_name>
    </contact_backup>
    <investigator>
      <last_name>Michele C. Walsh, MD MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Research Institute at Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pablo Sanchez, MD</last_name>
    </contact>
    <investigator>
      <last_name>Pablo Sanchez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Univeristy of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Eichenwald, MD</last_name>
    </contact>
    <investigator>
      <last_name>Eric Eichenwald, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brown University, Women &amp; Infants Hospital of Rhode Island</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abbot R. Laptook, MD</last_name>
    </contact>
    <investigator>
      <last_name>Abbot R. Laptook, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center at Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Myra Myckoff, MD</last_name>
    </contact>
    <investigator>
      <last_name>Myra Wyckoff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jon E Tyson, MD MPH</last_name>
    </contact>
    <investigator>
      <last_name>Jon E. Tyson, MD MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bradley Yoder, MD</last_name>
    </contact>
    <investigator>
      <last_name>Bradley A. Yoder, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://neonatal.rti.org</url>
    <description>Neonatal Research Network website</description>
  </link>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2013</study_first_submitted>
  <study_first_submitted_qc>February 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2013</study_first_posted>
  <last_update_submitted>January 24, 2018</last_update_submitted>
  <last_update_submitted_qc>January 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>NICHD Neonatal Research Network</keyword>
  <keyword>Hypoxic-ischemic encephalopathy (HIE)</keyword>
  <keyword>Hypothermia</keyword>
  <keyword>Neonatal depression</keyword>
  <keyword>Perinatal asphyxia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Hypothermia</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Hypoxia-Ischemia, Brain</mesh_term>
    <mesh_term>Hypoxia, Brain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>NIH has had a long-standing policy to share and make available to the public the results and accomplishments of the activities that it funds. The NRN plans to share de-identified data after final publication in an NIH supported data repository such as the NICHD Data and Specimen Hub (https://dash.nichd.nih.gov)</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

